Rationale and design of the CONFIRM-HF study: a double-blind, randomized, placebo-controlled study to assess the effects of intravenous ferric carboxymaltose on functional capacity in patients with chronic heart failure and iron deficiency: Rationale and design of CONFIRM-HF study
暂无分享,去创建一个
P. Ponikowski | A. Parkhomenko | G. Filippatos | D. J. Veldhuisen | L. Tavazzi | S. Anker | F. Ruschitzka | M. Komajda | T. McDonagh | G. Ertl | V. Levesque | B. Roubert | J. Comín-Colet | V. Mareev | Claudio Mori
[1] P. Ponikowski,et al. The additive burden of iron deficiency in the cardiorenal–anaemia axis: scope of a problem and its consequences , 2014, European journal of heart failure.
[2] Luigi Tavazzi,et al. Co‐morbidities in patients with heart failure: an analysis of the European Heart Failure Pilot Survey , 2014, European journal of heart failure.
[3] S. Solomon,et al. Analysing recurrent hospitalizations in heart failure: a review of statistical methodology, with application to CHARM‐Preserved , 2014, European journal of heart failure.
[4] P. Ponikowski,et al. Intravenous ferric carboxymaltose in iron-deficient chronic heart failure patients with and without anaemia: a subanalysis of the FAIR-HF trial , 2013, European journal of heart failure.
[5] J. Verdú,et al. Iron deficiency is a key determinant of health-related quality of life in patients with chronic heart failure regardless of anaemia status , 2013, European journal of heart failure.
[6] P. Ponikowski,et al. Health economic assessment of ferric carboxymaltose in patients with iron deficiency and chronic heart failure based on the FAIR-HF trial: an analysis for the UK , 2012, European journal of heart failure.
[7] L. A. Bonet,et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012 , 2010, European journal of heart failure.
[8] P. Ponikowski,et al. Anemia and iron deficiency in heart failure: mechanisms and therapeutic approaches , 2011, Nature Reviews Cardiology.
[9] P. Ponikowski,et al. Ferric carboxymaltose in patients with heart failure and iron deficiency. , 2009, The New England journal of medicine.